Information Provided By: 
Fly News Breaks for May 14, 2019
ISRG, TRXC
May 14, 2019 | 05:51 EDT
BTIG analyst Sean Lavin upgraded TransEnterix (TRXC) to Buy from Neutral with a $3 price target. The 40% pullback in the shares following the Q1 miss is overdone, Lavin tells investors in a research note. Individual issues at certain hospitals drove the shortfall, and there is a chance that next quarter and beyond could be better, says the analyst. He believes that while Intuitive Surgical (ISRG) using leasing to gain customers adds to TransEnterix's near-term risk, the shares offer more upside potential than downside risk at current prices.
News For TRXC;ISRG From the Last 2 Days
